Search Login Register

Oculocutaneous Albinism (Albinism, Yellow Mutant) Summary

261 relevant articles (1 outcomes, 9 trials/studies) found for this Disease

Description: Heterogeneous group of autosomal recessive disorders comprising at least four recognized types, all having in common varying degrees of hypopigmentation of the skin, hair, and eyes. The two most common are the tyrosinase-positive and tyrosinase-negative types.

Also Known As: Albinism, Yellow Mutant; Albinism, Oculocutaneous; Albinism, Tyrosinase Negative; Albinism, Tyrosinase Positive; Tyrosinase-Negative Albinism Show All >>

Key Drugs and Agents for Oculocutaneous Albinism

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Monophenol Monooxygenase (Tyrosinase) : 1 outcome 5 studies in 163 results : IBA
  2. Melanins (Melanin) : 1 study in 47 results : IBA
  3. Proteins (Proteins, Gene) : 1 study in 8 results : IBA
  4. Copper : 1 study in 5 results : IBA
  5. Type 1 Melanocortin Receptor : 1 study in 3 results : IBA
  6. Calcium : 1 study in 1 result : IBA
  7. Ceroid : 33 results : IBA
  8. Triad : 15 results : FDA 1
  9. Lipofuscin : 11 results : IBA
  10. Retinaldehyde (Retinal) : 8 results : IBA
Show All >>

Diseases Related to Oculocutaneous Albinism

  1. Syndrome
  2. Menkes Kinky Hair Syndrome (Menkes Disease)
  3. Neurofibromatoses (Neurofibromatosis)
  4. Exfoliative Dermatitis (Erythroderma)
  5. Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome)
Show All >>

Key Therapies for Oculocutaneous Albinism

Efficacy Chart >>
  1. Transplants (Transplant) : 1 result
  2. Intraocular Lens Implantation : 1 result
  3. Skin Transplantation (Skin Grafting) : 1 result

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.